Assignee
AMORSA THERAPEUTICS INC
US·7 granted patents·38 citations·filing 2014–2022
Top patents by PatentIndex Score
7 records- 0194US10653629B2Single layer oral dose of neuro-attenuating ketamineAMORSA THERAPEUTICS INC·Filed 2018·Granted May 19, 2020·6 cites·26 claims
- 0294US10252982B2Neuro-attenuating ketamine and norketamine compounds, derivatives thereof, and methodsAMORSA THERAPEUTICS INC·Filed 2015·Granted Apr 9, 2019·14 cites·48 claims
- 0393US11613515B2Neuro-attenuating ketamine and norketamine compounds, derivatives thereof, and methodsAMORSA THERAPEUTICS INC·Filed 2022·Granted Mar 28, 2023·2 cites·16 claims
- 0491US11554100B2Single-layer oral dose of neuro-attenuating ketamineAMORSA THERAPEUTICS INC·Filed 2020·Granted Jan 17, 2023·2 cites·17 claims
- 0590US11603348B2Neuro-attenuating ketamine and norketamine compounds, derivatives thereof, and methodsAMORSA THERAPEUTICS INC·Filed 2021·Granted Mar 14, 2023·1 cites·16 claims
- 0690US9913803B2Single-layer oral dose of neuro-attenuating ketamineAMORSA THERAPEUTICS INC·Filed 2014·Granted Mar 13, 2018·12 cites·17 claims
- 0785US10981859B2Neuro-attenuating ketamine and norketamine compounds, derivatives thereof, and methodsAMORSA THERAPEUTICS INC·Filed 2019·Granted Apr 20, 2021·1 cites·24 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →